Ornipressin Acetate hmoov

Ornipressin Acetate hmoov CAS 3397-23-7|High Purity Vasopressin V1A / V2 Receptor Agonist Peptide Supplier Tuam Tshoj

Core Muag Cov Ntsiab Lus

✅ Ntau dua lossis sib npaug li 98% HPLC Purity Research-Qib 32-mer Disulfide-Bonded Peptide Raw Khoom

✅ LC-MS Full-Length Sequence & Disulfide-Bridge Connectivity Verification

✅ Batch-Specific COA, HPLC & MS Test Reports Tau Txais Tau

✅ Optimized Fmoc-SPPS nrog tswj oxidative folding rau B-type natriuretic peptide, Hauv tsev Independent QC Laboratory

✅ Ntiaj teb no Export Documentation & Standard International Logistics Support

✅ Kev Cai Natriuretic-Series Peptide Analog Synthesis Service

Ornipressin Acetate hmoov(POR-8) yog ib qho hluavtaws cyclic vasopressin analogue peptide, featuring ornithine hloov ntawm txoj hauj lwm-8 ntawm arginine-vasopressin ib ntus, stabilized los ntawm intramolecular disulfide-bridge ntawm Cys1 thiab Cys6. Nws ua raws li kev xaiv agonist rau vasopressin V1A thiab V2 receptors, kho vasoconstriction, hemostatic nyhuv thiab lub raum hemodynamic modulation, dav siv nyob rau hauv cov hlab plawv pharmacology, vasopressin receptor mechanism, hepatorenal syndrome pre-clinical qauv thiab peptide qauv-kev sib raug zoo kev tshawb fawb.

Tsim los ntawm optimized Fmoc solid-phase peptide synthesis, tswj oxidative folding kom raug disulfide-bond cyclization thiab multi-theem gradient HPLC purification, pebOrnipressin Acetate hmoovnruj me ntsis tswj mis-folded disulfide isomers, deletion-sequence impurities thiab side-reaction by-products, ruaj ruaj receptor-binding bioactivity thiab zoo ib yam batch-to-batch kev ua tau zoo. HDM BIO ua haujlwm thoob ntiaj teb biochemistry cov chaw soj nstuam, kws tshuaj R&D cov chaw tsim khoom thiab cov chaw tsim tshuaj lom neeg, suav nrog milligram-theem lab kuaj mus txog rau kilogram-scale bulk procurement. Cov khoom siv peptide no tsuas yog txwv tsis pub siv rau kev tshawb fawb hauv chav kuaj thiab yuav tsum tsis txhob siv ncaj qha rau tib neeg kev tswj hwm kev kho mob.

Txhua pawg tsim khoom ntawm Ornipressin Acetate raug kuaj dual QC (HPLC + LC-MS) nyob rau hauv HDM BIO hauv-tsev analytical laboratory. Batch-specific COA yuav raug muab rau txhua qhov kev txiav txim ntau.

Rau cov neeg yuav khoom siv vasopressin-analog peptide raw cov ntaub ntawv rau kev tshawb fawb ntawm cov hlab plawv thiab lub raum, cov lus sib piv qhia meej qhov sib txawv tseem ceeb rau kev xaiv cov khoom nyoos:

Ntu no suav nrog cov ntsiab lus ntev-tails: ornipressin POR-8 peptide, vasopressin V1A agonist peptide raw khoom, ornithine-muaj cyclic tshawb fawb peptide.

Thaum muab khoomOrnipressin Acetate hmoovrau vasopressin-receptor pharmacology thiab lub raum-cardiovascular kev tshawb fawb ua ntej kev soj ntsuam, pab pawg R & D thiab cov neeg yuav khoom thoob ntiaj teb yuav tsum tau soj ntsuam tsib yam tseem ceeb kom tsis txhob muaj kev pheej hmoo txaus ntshai:

• HPLC purity validation: Paub meej ntau dua los yog sib npaug rau 98% HPLC purity nrog tag nrho impurity chromatogram; them nyiaj tshwj xeeb rau mis-folded disulfide-isomer impurities uas impair receptor-binding potency
• LC-MS cov qauv kev pom zoo: Txheeb xyuas qhov ntev-ntev 9-mer ib ntus suav nrog cov uas tsis yog-natural ornithine residue thiab paub meej tias qhov kev sib txuas ntawm intramolecular disulfide-bond
• Batch-specific documentation: Guarantee txhua qhov kev txiav txim tau txais kev ywj pheej batch COA, HPLC chromatogram thiab LC-MS disulfide-cov ntaub ntawv pov thawj
• Mature synthesis muaj peev xwm: Xaiv cov neeg muag khoom uas muaj pov thawj kev tsim khoom rau peptide uas tsis yog-canonical ornithine amino-acid thiab tswj oxidative-folding cyclization workflow
• Kev muaj peev xwm xa tawm thoob ntiaj teb: Paub meej tias tus neeg muag khoom tuaj yeem muab cov ntaub ntawv tiav rau kev lis kev cai thoob ntiaj teb

HDM BIO muab kev tshawb fawb-qib Ornipressin Acetate nrog tag nrho cov ntaub ntawv pov thawj zoo, MOQ yoog raws rau kev sim kuaj thiab kev yuav khoom mus sij hawm ntev.

Yog tias koj tab tom nrhiav Ornipressin Acetate hmoov nqe, cov lus hais ntau thiab cov nqe lus xa khoom, thov xa mus rau cov ntaub ntawv tseem ceeb raws li hauv qab no:

1. Yam tsawg kawg nkaus Order Quantity: Flexible MOQ, milligram & gram-scale kuaj kuaj kuaj muaj; kilogram-theem bulk mov rau kev tshawb fawb tej yaam num
2. Sample Access: Cov qauv sim rau kev soj ntsuam kuaj; hu rau pab neeg muag khoom kom tau txais cov qauv lus hais
3. Bulk Kilogram Pricing: Tiered pricing structure; loj bulk ntim coj kev sib tw chav tsev nqi
4. Lub Sijhawm Ua Haujlwm Ntau Lawm: Kev tuav tshwj xeeb yuav tsum tau ua rau cov uas tsis yog-natural ornithine lub tsev thaiv kev sib txuas ntxiv rau oxidative folding cyclization; kev muag khoom yuav lees paub lub sijhawm tsim khoom raws sijhawm raws li kev nug
5. Shipping Options: kaw txias-pom zoo shipping; zam lub sijhawm ntev ntawm chav tsev kub; Peb muab cov ntawv xa nyiaj ua lag luam, cov ntawv ntim khoom thiab MSDS rau kev lis kev cai thoob ntiaj teb

Kev hais lus kawg yog cuam tshuam los ntawm qib purity, disulfide-bond validation cov khoom, ntim tshwj xeeb thiab cov nqi txias-chain-logistics. Thov hu rau peb pab neeg muag khoom kom paub cov lus hais tawm tshiab.

HDM BIO muaj ntau tshaj 10-xyoo kev txawj ntse hauv Fmoc solid-phase peptide synthesis thiab complex cyclic vasopressin-tsev neeg peptide manufacturing, suav nrog peptides koom nrog cov tsis-canonical amino-acid residues.

• Dedicated SPPS cov kab ntau lawm; optimized coupling raws tu qauv rau Fmoc-Orn tsev-thaiv kom txo tau deletion-Orn impurities; kaw-system oxidative-folding teeb rau controllable disulfide-bridge cyclization
• Kev ywj pheej analytical laboratory nruab nrog HPLC, LC-MS, ya raws tester thiab hnyav-hlau-ntaus ntsuas; Tshwj xeeb LC-MS workflow rau disulfide-pairing qhia thiab mis-folded-isomer impurity quantification
• Peptide cov khoom xa tawm mus rau ntau dua 70 lub teb chaws, txhawb nqa tsev kawm ntawv labs, biotech startups thiab kws tshuaj R & D lub koom haum
• Muaj peev xwm tsim tau txhua xyoo ruaj khov rau kev tshawb fawb-qib peptide raw cov ntaub ntawv, txhawb kev koom tes ua haujlwm ntev
• Pab pawg kws tshaj lij tau paub txog hauv vasopressin-peptide-series synthesis, oxidative-folding-txoj kev optimization thiab lwm yam kev hloov kho analog.

Peb lub chaw tsim khoom peptide khiav Fmoc-SPPS cov kab ntau lawm, hauv tsev npaj-HPLC purification thiab ua tiav LC-MS analytical workflow rau disulfide-muaj cov peptides complex.

Ornipressin Acetate yog ib qho cyclic 9-mer vasopressin analog uas tsis yog-protein-ogenic ornithine residue thiab ib qho intramolecular disulfide-bridge. Kev tswj cov ornithine-deletion impurities, kho oxidative cyclization thiab suppressing mis-paired disulfide isomers yog cov tseem ceeb kev bottlenecks cais cov tsim nyog peptide manufacturers los ntawm cov neeg muag khoom qis.

Cov teeb meem tseem ceeb ntawm kev tsim khoom:

• Non-natural Fmoc-Ornithine lub tsev-thaiv ua rau muaj kev pheej hmoo siab dua ntawm kev sib txuas tsis tiav, tsim cov ornithine-deletion ntsig txog impurities uas nyuaj rau tshem tawm los ntawm cov pa HPLC purification.
• Oxidative folding cyclization kauj ruam yuav tsum nruj me ntsis tswj pH, kub thiab peptide concentration; Cov xwm txheej tsis tsim nyog tsim cov khoom tsis sib xws disulfide isomers nrog txo qis V1A / V2 receptor-binding potency.
• Cysteine ​​residues raug oxidation thaum lub sij hawm cleavage, folding thiab lyophilization workflow, tsim sulfoxide impurities
• Cyclic peptide conformation nce aggregation txaus ntshai thaum lub sij hawm synthesis thiab purification, txo tag nrho cov txheej txheem tawm los
• Txawm tias tag nrho HPLC purity siab tsis tuaj yeem lav qhov tseeb disulfide kev sib txuas thiab kev sib koom ua ke ntawm ornithine; tshwj xeeb LC-MS tag nrho-qib daim ntawv qhia kev sim yog qhov yuav tsum tau ua rau kev ua haujlwm vasopressin-receptor biology kuaj

HDM BIO siv segment-optimized SPPS coupling parameters rau ornithine residue, tag nrho-txheej txheem tiv thaiv oxidation tiv thaiv rau cysteine thiol pawg, nruj-tswj kaw-system oxidative-folding cyclization tej yam kev mob, multi-theem high-resolution npaj-HPLC cais mis-folded tag nrho isomers & disomide-LC-isomers. kev soj ntsuam tas li. Cov kev ntsuas no txo ​​qis ornithine-deletion, cysteine-oxidation thiab mis-folding impurities, kom ntseeg tau tias muaj tseeb 9-mer cyclic peptide thawj & tertiary qauv thiab ruaj khov batch-to-batch lom neeg ua haujlwm.

Ornipressin Acetate yuav tsum muaj kev tswj tag nrho cov txheej txheem rau ornithine residue coupling, cysteine ​​anti-oxidation, tswj oxidative folding cyclization kom raug disulfide-bridge thiab acetate- ntsev tsis-pauv thoob plaws synthesis, cleavage, folding, purification thiab lyophilization.

Nyeem cov lus qhia ntsig txog: Disulfide-Containing Peptide API Manufacturing Guide|Fmoc SPPS Technology piav qhia

Ua kom tiav Ornipressin Acetate Powder Manufacturing Workflow

Raw-material QC ntawm Fmoc-amino-acid tsev blocks (xws li Fmoc-Orn, Cys, Tyr residues) → 9-mer SPPS step-wise coupling nrog ornithine-fragment optimized raws tu qauv → Resin cleavage & ntiaj teb no deprotection nyob rau hauv anti-oxidation tiv thaiv folding predementation → Daim phiaj hom phiaj intramolecular disulfide-bridge → Multi-theem npaj-HPLC purification (tshem tawm deletion-peptide, mis-folded isomers & cysteine-oxidized impurities) → Buffer-exchange rau acetate- ntsev tsim → Nqus lyophilization → Full QC kev sib txuas-kev sib txuas Kev pov thawj, impurity profileing) → Batch COA muab → Lub teeb-pov thawj, tsis muaj dej noo ntim ntim

QC Kev Tshawb Fawb Kev Ua Haujlwm

Cov khoom siv raw QC → In-process coupling & aggregation risk monitoring → HPLC purity test → LC-MS molecular-weight, full-sequence & disulfide-connectivity verification → Cysteine-sulfoxide impurity quantitative analysis → Moisture & heavy-metal testing rel-sibroval → Residal-metal →

Cov txheej txheem tseem ceeb

Tshwj xeeb coupling parameter teem rau non-natural ornithine tsev-thaiv kom suppress Orn-deletion impurities

Tag nrho-workflow anti-oxidation shielding los txo cysteine ​​thiol oxidative degradation

Kaw-loop pH-kub-kub-tswj oxidative-folding cyclization system kom ua kom raug disulfide-bridge tsim tus nqi

Multi-step high-resolution HPLC cais cov qauv-zoo li mis-folded disulfide isomers thiab deletion-sequence peptide impurities

LC-MS tag nrho-sequence & disulfide-mapping paub tseeb tseeb tseeb Cys1-Cys6 khub thiab ornithine incorporation

Cov txheej txheem acetate-salt buffer-exchange guaranteeing zoo ib yam counter-ion daim ntawv; lyophilized khoom ruaj khov khaws cia ntawm -20 degree; aqueous tov susceptible rau oxidation & aggregation, aliquot thiab cia ntawm −80℃tam sim ntawd tom qab reconstitution, tsis txhob rov qab freeze-thaw mus.

1. Vasopressin receptor pharmacology tshawb fawb: V1A / V2 receptor binding assay, ligand selectivity kev tshuaj ntsuam, vasopressin analog qauv-kev sib raug zoo-kev tshawb nrhiav
2. Kev tshawb fawb plawv thiab lub raum physiology: Vasoconstriction mechanism, kev tshawb fawb hemostasis, raum hemodynamic cell thiab pre-clinical tsiaj-qauv thwmsim
3. Hepatorenal-syndrome ntsig txog kev tshawb fawb txog kab mob: Lub siab ua haujlwm rau lub raum tsis ua haujlwm ua ntej kev kho mob qauv, vasopressin-mediated organ crosstalk kev tshawb nrhiav
4. Kev txhim kho Peptide: Lyophilized-formulation feasibility tshawb fawb, vasopressin-analog peptide tus me nyuam-kev txhim kho
5. Biomedical reagent npaj: Laboratory siv cov qauv thiab kev sim-tswj reagents rau vasopressin-tsev neeg peptide kev tshawb fawb
6. Tshwj xeeb-amino-acid peptide-process-development research: Ornithine-muaj cyclic disulfide-bonded peptide synthesis & impurity-control benchmark compound

• 10+-xyoo Tuam Tshoj-based peptide-tsim kev tsim khoom, tshwj xeeb hauv cyclic disulfide-bonded vasopressin-tsev neeg peptides nrog kev hloov pauv tsis yog-natural amino-acid
• Mature optimized SPPS ntxiv rau kaw-system oxidative-folding workflow, zoo txo ​​ornithine-deletion, cysteine-oxidation thiab mis-folded disulfide-isomer impurities
• Full-batch LC-MS full-sequence & disulfide-connectivity validation thiab ua tiav impurity-profile tswj rau txhua qhov ntau lawm
• Ua kom tiav batch-wise production-traceability cov ntaub ntawv rau Ornipressin Acetate
• Muaj peev xwm muab tau yooj yim: milligram lab kuaj rau kilogram-scale bulk peptide xaj
• Ntiaj teb no-export kev pab cuam npog ntau tshaj 70 lub teb chaws thoob ntiaj teb
• Cov kws tshaj lij pab pawg txhawb nqa kev tshawb fawb vasopressin-peptide thiab kev sib tham txog kev cai-analog synthesis

Q: Kuv puas tuaj yeem yuav Ornipressin Acetate hmoov los ntawm Tuam Tshoj?A: HDM BIO yog Tuam Tshoj complex cyclic disulfide-muaj vasopressin-analog peptide tus neeg muab khoom xa tawm siab-purityOrnipressin Acetate hmoovrau thoob ntiaj teb kws tshuaj R & D pab pawg thiab bioreagent kuaj. Peb muab cov qauv tshawb fawb me me thiab cov xaj loj loj, nrog rau cov ntaub ntawv xa tawm tag nrho thiab cov khoom lag luam thoob ntiaj teb-kev txhawb nqa.

Q: Cov ntaub ntawv dab tsi yuav tsum yog tus tsim nyog Ornipressin Acetate muab?A: Cov neeg muag khoom ntseeg siab yuav tsum muab cov khoom tshwj xeeb COA, HPLC chromatogram, LC-MS tag nrho-sequence & disulfide-kev sib txuas-kev txheeb xyuas daim ntawv qhia, MSDS thiab ua tiav cov ntaub ntawv tsim tawm-traceability; ornithine-deletion thiab mis-folded-isomer impurity-testing cov ntaub ntawv muaj nyob rau ntawm kev thov.

Q: Tus lej CAS ntawm Ornipressin Acetate yog dab tsi?

A: Tus lej CAS npe ntawm Ornipressin Acetate yog 3397-23-7.

Q: Dab tsi purity qib ntawm Ornipressin Acetate hmoov koj tuaj yeem xa?

A: Txuj kev tshawb fawb-qib Ntau dua lossis sib npaug rau 98% HPLC purity. Cov ntsiab lus siab dua-purity thiab vasopressin-series kev cai-peptide-analog synthesis yog muaj rau kev sim tshwj xeeb.

Q: Yuav ua li cas lyophilized Ornipressin Acetate hmoov khaws cia?

A: Khaws kaw ntawm -20 degree, kom deb ntawm lub teeb thiab noo noo. Ua nruj ua tsiv kom tsis txhob rov qab khov-thaw cycles. Aqueous reconstituted tov yog raug rau oxidation thiab aggregation; npaj ib leeg-siv aliquots thiab khaws cia ntawm −80 degree, lub sij hawm ntev cia nyob rau hauv 2-8℃tsis pom zoo.

Q: Kuv puas tuaj yeem tau txais Ornipressin Acetate kuaj ua ntej yuav ntau?

A: Yog. Peb muab cov qauv sim ntsuas milligram-rau-gram-theem txuas nrog ua tiav COA thiab cov ntaub ntawv xeem suav nrog cov ntawv pov thawj disulfide-daim ntawv pov thawj rau kev kuaj xyuas.

Q: MOQ rau bulk Ornipressin Acetate hmoov yog dab tsi?

A: MOQ yog hloov tau raws li qib purity thiab ntim specifications. Peb txhawb nqa cov kev tshawb fawb me me thiab cov xaj loj loj rau ntau qhov kev xav tau.

Q: Dab tsi yog qhov amino-acid sequence ntawm Ornipressin Acetate?

A: c[Cys-Tyr-Phe-Gln-Asn-Cys]-Pro-Orn-Gly-NH₂, disulfide-bond Cys1-Cys6, acetate ntsev.

Tshuaj xyuas los ntawm:

HDM BIO Peptide Technical Team

Kev txawj ntse:

Peptide synthesis Non-natural-amino-acid hloov cyclic disulfide-bonded vasopressin-tsev neeg peptide manufacturing Analytical chemistry & disulfide-isomer / deletion-impurity profiling

Peb xa ib qho kev pabcuam tag nrho rau kev pabcuam thoob ntiaj teb peptide thiab biopharmaceutical R & D cov haujlwm:

• Batch - tshwj xeeb COA
• MSDS Safety Data Sheet
• Cov ntaub ntawv pov thawj GMP & ISO
• Custom Bulk Lag luam wholesale Nqe
• Cov qauv dawb muaj
• Dedicated Technical Formulation Support

Thov COA Tau Txais Tus Nqi Them Nqi Thov Tus Qauv

WhatsApp: +86 19991242181

Email:sales@hdmbio.com

Cim npe nrov: Ornipressin acetate hmoov, Tuam Tshoj Ornipressin acetate hmoov manufacturers, lwm tus neeg, Hoobkas